FDA Inspection 1276594 — CTON Corporation

CTON Corporation — FEI 3012098634

The FDA completed an inspection of CTON Corporation on July 25, 2025 in Torrance, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 25, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Torrance, CA (United States)

Citations

IDCFRDescription
1231021 CFR 1271.160(a)All core requirements covered in program
1233621 CFR 1271.180(a)Procedures to meet core CTGP
1243721 CFR 1271.270(a)Records incomplete